1

U.S. Biosimilars: $8.6B → $65.6B by 2033 (25.5% CAGR)

 News Discuss 
The U.S. biosimilars market was valued at US $8.62 billion in 2024 and is forecast to reach US $65.62 billion by 2033, growing at a 25.5 % CAGR https://www.datamintelligence.com/research-report/us-biosimilars-market

Comments

    No HTML

    HTML is disabled


    Report Page

Who Upvoted this Story

Search

Published News